-
Halozyme Therapeutics, Inc. (NASDAQ:HALO) Given Average Rating of "Moderate Buy" by Brokerages
Source: Buzz FX / 07 Feb 2025 02:06:10 America/Chicago
Halozyme Therapeutics, Inc. (NASDAQ:HALO) Given Average Rating of "Moderate Buy" by Brokerages Written by MarketBeat February 7, 2025 Share Link copied to clipboard. Shares of Halozyme Therapeutics, Inc.
Read more...